BioSpace News Archive

XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that the Company is participating in the BIO CEO and Investor Digital Conference to be held virtually February 16-18, 2021.

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the fourth quarter and full year of 2020 on Wednesday, March 3rd, 2021 .

[17-February-2021] Montreal Heart Institute study to evaluate the ability of hesperidin, the medicinal ingredient in Hesperco™ capsules, to reduce the severity of symptoms and the need for hospitalization in COVID-19 patients Hesperidin interferes / inhibits 2 key proteins of SARS-CoV-2 necessary for entry and infection of cells, suggesting that hesperidin may disrupt the replication rate of

Century Therapeutics announced a significant expansion of its operational and laboratory space in Philadelphia, as well as progress on its manufacturing facility in Branchburg, NJ, paving the way for a strong technical foundation as the company scales up its in-house research and development capabilities.

A new microsatellite instability (MSI) system launched today by Promega Corporation enables cancer researchers to evaluate a new set of unique MSI markers that may offer additional precision in the characterization of their tumor samples.

Data from an in vitro study of Anaconda Biomed ’s Advanced Neurovascular Access TM (ANA) Catheter System to treat ischemic stroke have been published in the Journal of NeuroInterventional Surgery by investigators at Barcelona’s Hospital Vall d’Hebron.

Iron Pharmaceuticals to report 2020 results – LINZESS ® (linaclotide) 2020 U.S. net sales of $931 million, up 10% year-over-year; Ironwood expects 2021 U.S. LINZESS net sales growth of 3 to 5% –

Abiomed, Inc., a leading provider of breakthrough heart support technologies, announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the SVB Leerink 10th Annual Global Healthcare Conference on Wednesday, February 24th at 8:40am ET and the Raymond James 2021 Institutional Investors Conference on Tuesday, March 2nd at 10:50am ET.

Antigen Test Is the Latest Offering by Labcorp to Fight COVID-19 at Every Stage, from Diagnostic Testing to Clinical Trials and Vaccination Services

Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report fourth quarter and full year 2020 financial results before the open of U.S. financial markets on Wednesday, February 24, 2021. Kura’s management will host a webcast and conference call at 8:00 a.m. ET / 5:00 a.m. PT that day to discuss the financial r